Total Payments
$8,115
2024 Payments
$7,992
Companies
13
Transactions
127
Medicare Patients
413
Medicare Billing
$57,971
Payment Breakdown by Category
Consulting$5,075 (62.5%)
Food & Beverage$2,137 (26.3%)
Travel$903.63 (11.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,075 | 2 | 62.5% |
| Food and Beverage | $2,137 | 121 | 26.3% |
| Travel and Lodging | $903.63 | 4 | 11.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $6,054 | 11 | $0 (2024) |
| Amgen Inc. | $685.80 | 58 | $0 (2024) |
| Novo Nordisk Inc | $334.86 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $282.29 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $244.83 | 9 | $0 (2024) |
| Eisai Inc. | $98.28 | 5 | $0 (2024) |
| Exact Sciences Corporation | $86.04 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $85.43 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $80.98 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $53.52 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,992 | 122 | Lilly USA, LLC ($6,054) |
| 2023 | $122.81 | 5 | Novo Nordisk Inc ($43.49) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $1,325.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Inflammation | ||||||
| 12/07/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $173.34 | General |
| 12/06/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $463.51 | General |
| 12/06/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $173.34 | General |
| 12/06/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $93.44 | General |
| 12/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 111 | 141 | $49,080 | $15,393 |
| 2022 | 5 | 135 | 167 | $53,921 | $16,261 |
| 2021 | 2 | 45 | 79 | $18,879 | $6,560 |
| 2020 | 4 | 122 | 238 | $50,920 | $19,758 |
Total Patients
413
Total Services
625
Medicare Billing
$57,971
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 37 | 59 | $18,998 | $6,453 | 34.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 20 | 20 | $7,940 | $2,650 | 33.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 15 | 19 | $6,118 | $2,225 | 36.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 14 | 14 | $5,558 | $1,813 | 32.6% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 11 | 13 | $5,538 | $1,276 | 23.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 14 | 16 | $4,928 | $977.50 | 19.8% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 33 | 53 | $17,066 | $5,386 | 31.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 28 | 29 | $11,513 | $3,602 | 31.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 24 | 28 | $9,016 | $2,851 | 31.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 13 | 14 | $5,558 | $1,762 | 31.7% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 11 | 12 | $3,876 | $1,028 | 26.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 13 | 16 | $3,472 | $903.47 | 26.0% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 13 | 15 | $3,420 | $729.40 | 21.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 22 | 45 | $11,169 | $3,741 | 33.5% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 12 | 21 | $5,466 | $2,077 | 38.0% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 11 | 13 | $2,244 | $741.40 | 33.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 56 | 145 | $34,945 | $13,751 | 39.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 21 | 36 | $5,832 | $1,999 | 34.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 13 | 15 | $3,615 | $1,585 | 43.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 21 | 30 | $3,660 | $1,411 | 38.5% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 11 | 12 | $2,868 | $1,012 | 35.3% |
About Dr. Afriyie Gray, DO
Dr. Afriyie Gray, DO is a Geriatric Medicine healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1477842904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Afriyie Gray, DO has received a total of $8,115 in payments from pharmaceutical and medical device companies, with $7,992 received in 2024. These payments were reported across 127 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($5,075).
As a Medicare-enrolled provider, Gray has provided services to 413 Medicare beneficiaries, totaling 625 services with total Medicare billing of $57,971. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Grand Rapids, MI
- Active Since 04/05/2011
- Last Updated 11/04/2024
- Taxonomy Code 207QG0300X
- Entity Type Individual
- NPI Number 1477842904
Products in Payments
- KISUNLA (Drug) $5,075
- Otezla (Drug) $559.02
- Rybelsus (Drug) $196.59
- AREXVY (Drug) $135.15
- FARXIGA (Drug) $129.17
- Ozempic (Drug) $117.11
- Leqembi (Drug) $98.28
- TRELEGY ELLIPTA (Drug) $96.52
- Cologuard Collection Kit (Device) $86.04
- CAPLYTA (Drug) $85.43
- KRYSTEXXA (Biological) $81.56
- REXULTI (Drug) $80.98
- BREZTRI (Drug) $80.96
- MOUNJARO (Drug) $75.68
- AIRSUPRA (Drug) $72.16
- Kerendia (Drug) $53.52
- Repatha (Biological) $45.22
- NEXLETOL (Drug) $43.48
- APTIMA (Device) $39.05
- GEMTESA (Drug) $26.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Grand Rapids
Karen Gawel, Md, MD
Geriatric Medicine — Payments: $1,671
Geriatric Medicine $1,671
Dr. Mary Ball, M.d, M.D
Geriatric Medicine — Payments: $710.43
Geriatric Medicine $710.43
Venkatanagaraja Vadlamudi, Md, MD
Geriatric Medicine — Payments: $287.21
Geriatric Medicine $287.21
Kathleen Mosentine, Md, MD
Geriatric Medicine — Payments: $73.28
Geriatric Medicine $73.28
Dr. June Jones, Md, MD
Geriatric Medicine — Payments: $14.30
Geriatric Medicine $14.30
Jayne Courts, M.d, M.D
Geriatric Medicine
Geriatric Medicine